Keywords: Alzheimer's Disease, Alzheimer's Disease
Motivation: A reduction in brain metabolism is a hallmark of neurodegeneration in Alzheimer’s disease (AD), according to recent criteria for staging AD. However, alterations in brain metabolism during the preclinical phase of AD are not fully understood.
Goal(s): To investigate the association between brain metabolism and cognitive performance at a very early stage of dementia, when cognition is still normal.
Approach: Using non-invasive MRI, we measured cerebral metabolic rate of oxygen (CMRO2) and examined its association with cognitive test scores.
Results: CMRO2 was lower in participants with MCI/dementia compared to those cognitively unimpaired. However, among the unimpaired group, CMRO2 was inversely associated with cognition.
Impact: The present work suggests that, at the very early stage of Alzheimer’s disease, higher brain oxygen metabolism is a sign of lower cognitive function, reflecting brain's hypermetabolism/hyperactivity during preclinical neurodegeneration.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords